SSRIs and SNRIs for vasomotor symptoms of menopause
Consider an SNRI or SSRI for individuals with hot flushes and mood symptoms.
Escitalopram is the most effective SSRI for improving vasomotor symptoms, quality of life and sleep, and has the fewest adverse effects (including sexual adverse effects). Fluoxetine and paroxetine inhibit cytochrome P450 and may reduce the active metabolite of tamoxifen; avoid concurrent use.
Venlafaxine and desvenlafaxine can also be used for vasomotor symptoms, and can improve sleep, mood and quality of life.
See ../../Psychotropic/ptg/c_ptg8-c68-s1.html#ptg8-c68-s1__tptg8-c68-tbl2 for an overview of adverse effects of SSRIs and SNRIs.
Suitable SSRI regimens include:
1 citalopram 10 mg orally in the morning, increasing if needed every 2 to 4 weeks to a maximum of 20 mg once daily menopause, vasomotor symptoms citalopram
OR
1 escitalopram 5 mg orally in the morning, increasing if needed every 2 to 4 weeks to a maximum of 20 mg once daily menopause, vasomotor symptoms escitalopram
OR
1 fluoxetine 10 mg orally, in the morning, increasing if needed every 2 to 4 weeks to a maximum of 30 mg once daily menopause, vasomotor symptoms fluoxetine
OR
1 paroxetine 10 mg orally, in the morning, increasing if needed every 2 to 4 weeks to a maximum of 20 mg once daily. menopause, vasomotor symptoms paroxetine
Suitable SNRI regimens include:
1 desvenlafaxine 50 mg orally in the morning, increasing if needed every 2 to 4 weeks to a maximum of 150 mg menopause, vasomotor symptoms desvenlafaxine
OR
1 venlafaxine 37.5 mg orally, in the morning, increasing if needed every 2 to 4 weeks to a maximum of 75 mg once daily. menopause, vasomotor symptoms venlafaxine
Some benefit may be expected within 4 weeks of starting therapy, but full effects may take up to 8 weeks. If stopping therapy, reduce doses gradually to avoid withdrawal symptoms. If switching from one SSRI or SNRI to another, see Switching antidepressants.